Back
AbbVie Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer3.jpg)
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.
Buy
68
ABBV
AbbVie
Last Price:
185.15
Seasonality Move:
-0.45%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.AbbVie Price Quote
$185.15
+2.98 (+1.64%)
(Updated: July 26, 2024 at 6:55 PM ET)
AbbVie Key Stats
Buy
68
AbbVie (ABBV)
is a Buy
Day range:
$171.80 - $186.11
52-week range:
$135.85 - $186.11
Dividend yield:
3.37%
P/E ratio:
66.97
P/S ratio:
5.94
P/B ratio:
40.18%
Volume:
9.4M
Avg. volume:
5.8M
1-year change:
28.62%
Market cap:
$321.7B
Revenue:
$54.3B
EPS:
$3.37
How Much Does AbbVie Make?
Is AbbVie Growing As A Company?
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
-
Is AbbVie Stock Overvalued?
AbbVie is trading at a price to free cash flow ratio of 14.75 -
Is AbbVie Stock Undervalued?
AbbVie EV to Free Cash Flow ratio is 17.25 -
What Is AbbVie’s Price Earnings Growth Ratio?
ABBV PEG ratio is 0.00 -
Is AbbVie Trading At A Premium To Earnings?
AbbVie EV to EBIT ratio is 38.30
Is It Risky To Buy AbbVie?
Is AbbVie Cash Flow Positive?
AbbVie Return On Invested Capital
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?
A single share of ABBV can be purchased today for 182.17 -
What Is AbbVie’s Stock Symbol?
AbbVie trades on the S&P500 under the ticker symbol: ABBV -
When Is AbbVie’s Next Earnings Date?
The next quarterly earnings date for AbbVie is scheduled on October 25, 2024 -
When Is ABBV's next ex-dividend date?
AbbVie's next ex-dividend date is July 15, 2024 -
How To Buy AbbVie Stock?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 492.31% | -0.39% |
Revenue: | 0.7% | 3.1% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 10 |
Sell Recommendations: | 0 |
Price Target: | 187.74 |
Upside from Last Price: | 3.06% |